Industry & Policy News

[Prevent Cancer Foundation] “From training the country’s first breast radiologists in Zambia and testing AI-supported breast cancer diagnosis in Nigeria to implementing novel approaches for addressing cervical cancer in Cameroon and Mexico, the Prevent Cancer Foundation is proud to support the 2024 Global Innovation Grants as we dare to imagine a world where cancer is preventable, detectable and beatable for all,” said CEO Jody Hoyos

[Science] Researchers hope some of the first rigorous placebo-controlled clinical trials of possible Long Covid treatments will report outcomes, though they may be preliminary.

[BiopharmaDive] Goldman Sachs Asset Management has wrapped up fundraising for the first fund in its Life Sciences investment venture, securing $650 million in equity commitments.

[PharmaTimes] Deepcell has entered into a research collaboration with NVIDIA to accelerate the use of generative artificial intelligence (AI) in single cell research for cancer, stem cells and cell therapies.

[University of Cambridge] The BEST4 trial launched at Addenbrooke’s Hospital was the final step to see if the capsule sponge, known as the pill-on-a-thread, can prevent oesophageal cancer when used to screen or monitor those most at risk of the disease.

[The University of Alabama at Birmingham] Elizabeth E. Brown, M.P.H., Ph.D. and Lalita Shevde-Samant, Ph.D., are co-leading a new research education program entitled University of Alabama at Birmingham Enhancing Research in Cancer-related Health Professions with support from the National Cancer Institute.